Teva Fails To Uncover Plans For Generic Copaxone

Law360, New York (October 12, 2010, 6:58 PM EDT) -- Teva Pharmaceuticals USA Inc. has lost its bid to force Sandoz Inc. and Momenta Pharmaceuticals Inc. to provide advance notice of their intent and ability to launch a generic version of Teva's multiple sclerosis drug Copaxone.

Judge Barbara S. Jones of the U.S. District Court for the Southern District of New York on Tuesday denied Teva's request for an order directing the generic-drug makers to provide the court and Teva with 10 days' notice prior to the launch of a copycat version, ruling that the defendants...
To view the full article, register now.